INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

81,159 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
FG
Foletta Mark GDirector
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A—
20.0K sh
Mar 11, 2026Mar 13, 2026
Page 1402 of 2029
← PrevNext →
traded Mar 11, 2026
+2d
SEC Form 4

Evidence

9
KM
Kelly Kevin MASST. GENERAL COUNSEL/SEC.
SPGSIMON PROPERTY GROUP INC.
Grant or award
A$781
3,124 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

9
GM
Gonzalez Julie MarieDirector
FFIVF5, INC.
Option exercise
M—
934 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

9
SK
Sykes KarenPRESIDENT, CMO DD'S DISCOUNTS
ROSTROSS STORES, INC.
Grant or award
A—
6,577 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

9
LC
Lapointe ChristopherCFO and PAO
SOFISoFi Technologies, Inc.
Grant or award
A—
233.7K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

9
MK
Mulally Ryan KEVP, Gen'l Counsel, Secretary
DPZDOMINOS PIZZA INC
Tax withholding
F$8,652
22 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

9
GS
Gilligan SarahChief Sup Chn & Transform Ofcr
GAPGAP INC
Option exercise
M—
10.7K sh
Mar 13, 2026Mar 13, 2026
traded Mar 13, 2026
+0dSEC Form 4

Evidence

9
GD
Giles Jeffrey DEVP, Corporate Development
CNMCore & Main, Inc.
Grant or award
A—
21.6K sh
Mar 12, 2026Mar 13, 2026
traded Mar 12, 2026
+1dSEC Form 4

Evidence

9
HS
Hammock SamanthaEVP & Chief HR Officer
VZVERIZON COMMUNICATIONS INC
Grant or award
A$989
68 sh
Mar 12, 2026Mar 13, 2026
traded Mar 12, 2026
+1dSEC Form 4

Evidence

9
FG
Frey Donald GEVP, TREASURER
SPGSIMON PROPERTY GROUP INC.
Grant or award
A—
990 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

9
AA
Andonian Andre'Director
ADIANALOG DEVICES INC
Tax withholding
F$37K
116 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

9
NA
Narang AmanDirector, CEO
TOSTToast, Inc.
Derivative conversion
C—
300.0K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

9
MM
Murphy Kevin MichaelDirector, See Remarks
FERGFerguson Enterprises Inc. /DE/
Grant or award
A—
28.6K sh
Mar 12, 2026Mar 13, 2026
traded Mar 12, 2026
+1dSEC Form 4

Evidence

9
TT
Thees William T. JrChief Operating Officer
FERGFerguson Enterprises Inc. /DE/
Grant or award
A—
4,653 sh
Mar 12, 2026Mar 13, 2026
traded Mar 12, 2026
+1dSEC Form 4

Evidence

9
MK
Mukkamala Himagiri KChief Operating Officer
QTWOQ2 Holdings, Inc.
Grant or award
A—
15.4K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

9
NJ
Nance Jeremy JohnSVP and General Counsel
VVXV2X, Inc.
Tax withholding
F$31K
440 sh
Mar 12, 2026Mar 13, 2026
traded Mar 12, 2026
+1dSEC Form 4

Evidence

9
MK
Mukkamala Himagiri KChief Operating Officer
QTWOQ2 Holdings, Inc.
Grant or award
A—
15.4K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

9
MR
Mason Leon Roger Jr.Chief Growth Officer
VVXV2X, Inc.
Option exercise
M—
4,469 sh
Mar 12, 2026Mar 13, 2026
traded Mar 12, 2026
+1dSEC Form 4

Evidence

9
CA
Carter Bruce L ADirector
ENTAENANTA PHARMACEUTICALS INC
Grant or award
A—
20.0K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

9
HJ
Holly Thomas JosephDirector
CHCIComstock Holding Companies, Inc.
Grant or award
A—
969 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

9
VA
Villanueva Rodriguez AlfonsoEVP&Int.Group CEO-VZ Cons.&CTO
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,046
72 sh
Mar 12, 2026Mar 13, 2026
traded Mar 12, 2026
+1dSEC Form 4

Evidence

8
FM
Fong MorganGENERAL COUNSEL & SECRETARY
CARTMaplebear Inc.
Open-market sale · 10b5-1 plan
SELL$186K
4,955 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

8
PB
Pfeiffenberger BrentDirector, President and CEO
IPSCCentury Therapeutics, Inc.
Tax withholding
F$151K
55.4K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

8
TN
Tanious Jubran N.President & COO
SVVSavers Value Village, Inc.
Option exercise
M$141K
100.0K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

6
CM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$36K
500 sh
Mar 13, 2026Mar 13, 2026
traded Mar 13, 2026
+0dSEC Form 4

Evidence

5
RJ
Rishel JeremyChief Technology Officer
SOFISoFi Technologies, Inc.
Grant or award
A—
181.8K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

5
MK
Mukkamala Himagiri KChief Operating Officer
QTWOQ2 Holdings, Inc.
Grant or award
A—
7,708 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

5
SE
Schuppenhauer EricEVP GBUL Borrow
SOFISoFi Technologies, Inc.
Grant or award
A—
103.9K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

5
CC
Cowan ChadChief Scientific Officer
IPSCCentury Therapeutics, Inc.
Tax withholding
F$3,907
1,431 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

5
PA
Pinto ArunChief Risk Officer
SOFISoFi Technologies, Inc.
Grant or award
A—
155.8K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

5
HT
Hamilton Brian TDirector, President of CCBX
CCBCOASTAL FINANCIAL CORP
Grant or award
A—
2,714 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

5
CL
Coleman Kirk LChief Business Officer
QTWOQ2 Holdings, Inc.
Grant or award
A—
13.5K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

5
KK
Keough KelliEVP, GBUL, SIPS
SOFISoFi Technologies, Inc.
Grant or award
A—
90.9K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

5
CL
Coleman Kirk LChief Business Officer
QTWOQ2 Holdings, Inc.
Grant or award
A—
6,746 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

5
CD
Chudova DaryaChief Technology Officer
GHGuardant Health, Inc.
Grant or award
A—
23.9K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

5
CL
Coleman Kirk LChief Business Officer
QTWOQ2 Holdings, Inc.
Grant or award
A—
13.5K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

5
CS
Campbell Elizabeth SExecutive Vice President
CORCencora, Inc.
Option exercise
M—
12.6K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

5
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Grant or award
A—
13.6K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

4
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$28K
133 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence

3
KS
Kerr Michael SGeneral Counsel
QTWOQ2 Holdings, Inc.
Grant or award · 10b5-1 plan
A—
18.3K sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC Form 4

Evidence